Dr. Wallace Brucker Introduces Medically Supervised GLP-1 Healthy Living Program in Las Vegas Focused on Preserving Muscle Mass

As new data shows up to 40% of GLP-1 weight loss may be lean muscle, LV Longevity Lab pairs semaglutide and tirzepatide therapy with muscle-preservation protocols for safer, longer-lasting results
LAS VEGAS - July 25, 2026 - Amid growing concern that popular weight-loss medications may cost patients as much muscle as fat, Dr. Wallace Brucker, a board-certified surgeon and longevity medicine expert, has announced a medically supervised GLP-1 weight loss program at LV Longevity Lab [https://lvlongevitylab.com/] in Las Vegas designed specifically to preserve lean muscle while patients lose fat.

GLP-1 receptor agonists such as semaglutide and tirzepatide have transformed weight management, but long-term data emerging in 2025 and 2026 has surfaced a serious concern. Research indicates that a substantial portion of the weight lost on high-dose GLP-1 therapy is not fat but lean body mass, including skeletal muscle. Because muscle does not return as easily as fat, this loss can compromise strength, mobility, metabolism, and long-term health, particularly in adults over 50.

The Problem With Weight Loss That Ignores Muscle

The concern has prompted a shift in how leading physicians prescribe these medications. Rather than focusing solely on the number on the scale, longevity-focused clinicians now emphasize body composition - the ratio of fat to muscle - as the true measure of a healthy outcome.

"The scale is one of the most misleading tools in medicine," said Dr. Brucker. "A patient can lose thirty pounds and celebrate, while quietly losing the muscle that protects their metabolism, their mobility, and their independence for decades to come. Muscle is not cosmetic - it is the armor that carries you through a long, resilient life. My job is to make sure that when a patient loses weight on a GLP-1, they lose fat and keep muscle. Done correctly, these medications are extraordinary. Done carelessly, they can accelerate the very decline we're trying to prevent."

A Program Built Around Body Composition

Dr. Brucker's program combines medically supervised GLP-1 therapy with a structured muscle-preservation strategy grounded in the protocols now recommended by leading longevity physicians.

Every patient begins with comprehensive baseline testing, including detailed body composition analysis that measures lean mass and fat mass separately rather than relying on weight alone. This establishes a starting point and allows muscle to be tracked throughout treatment, so any early lean-mass loss is caught and corrected before it compromises results.

From there, treatment is built around several pillars working together. GLP-1 medication is prescribed at the lowest effective dose and titrated carefully, avoiding the rapid weight loss most associated with muscle depletion. Personalized nutrition emphasizes adequate protein intake to support muscle protein synthesis during weight loss. Resistance training guidance helps patients build and maintain the muscle that medication alone cannot protect. And because muscle maintenance depends heavily on hormonal health, the program integrates hormone evaluation and optimization when appropriate - addressing the testosterone, thyroid, and metabolic factors that influence how well the body preserves lean tissue.

For patients whose joint pain has prevented them from strength training, LV Longevity Lab's regenerative and movement therapies help restore the ability to exercise, removing a common barrier to muscle preservation.

Why Medical Supervision Matters

Dr. Brucker emphasizes that the difference between a healthy outcome and a harmful one often comes down to supervision and monitoring.

"Muscle loss on these medications frequently goes undetected until strength, mobility, or metabolism has already declined," he noted. "By then, you're playing catch-up. With the right monitoring - tracking body composition, not just weight - we can intervene early and keep patients on a path that improves their healthspan rather than undermining it. That's the entire philosophy of longevity medicine: measure what matters, and act before there's a problem."

A Uniquely Qualified Approach

Dr. Brucker brings an uncommon background to metabolic and body-composition medicine. A West Point graduate and board-certified orthopedic surgeon, he spent more than 30 years optimizing the performance and physical resilience of Navy SEALs and Special Forces personnel, later completing fellowship training in anti-aging medicine. That experience - centered on preserving strength, function, and durability under extreme demands - informs a philosophy in which muscle preservation is treated as essential to long-term health, not an afterthought.

The GLP-1 muscle-preservation program is available now to patients in Las Vegas and to those traveling for care. Patients interested in medically supervised weight loss that protects lean muscle are encouraged to contact the clinic.

About Dr. Wallace Brucker and LV Longevity Lab

Dr. Wallace Brucker is a West Point graduate, board-certified orthopedic surgeon, and longevity medicine expert who spent more than 30 years optimizing performance for elite military personnel. At LV Longevity Lab in Las Vegas, he provides proactive, longevity-focused medicine - including medically supervised weight management, hormone optimization, body-composition analysis, and personalized protocols - designed to help patients preserve health, function, and vitality throughout long, active lives.

Media Contact
Company Name: LV Longevity Lab
Contact Person: Dr. Wallace Brucker
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=dr-wallace-brucker-introduces-medically-supervised-glp1-healthy-living-program-in-las-vegas-focused-on-preserving-muscle-mass]
Phone: (702) 478-3369
Address:Margaret Brucker, PA-C LV Longevity Lab 4315 Dean Martin Dr, Unit 230E
City: Las Vegas
State: NV 89103
Country: United States
Website: https://lvlongevitylab.com

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.